These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22873578)

  • 1. Exploring uncharted territories: predicting activity cliffs in structure-activity landscapes.
    Guha R
    J Chem Inf Model; 2012 Aug; 52(8):2181-91. PubMed ID: 22873578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
    Hu Y; Bajorath J
    J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of activity cliffs using support vector machines.
    Heikamp K; Hu X; Yan A; Bajorath J
    J Chem Inf Model; 2012 Sep; 52(9):2354-65. PubMed ID: 22894655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs.
    Dimova D; Stumpfe D; Bajorath J
    J Med Chem; 2014 Aug; 57(15):6553-63. PubMed ID: 25014781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Interaction Hot Spots in Structures of Drug Targets on the Basis of Three-Dimensional Activity Cliff Information.
    Furtmann N; Hu Y; Gütschow M; Bajorath J
    Chem Biol Drug Des; 2015 Dec; 86(6):1458-65. PubMed ID: 26094578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing how well a modeling protocol captures a structure-activity landscape.
    Guha R; Van Drie JH
    J Chem Inf Model; 2008 Aug; 48(8):1716-28. PubMed ID: 18686944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical landscape analysis with the OpenTox framework.
    Jeliazkova N; Jeliazkov V
    Curr Top Med Chem; 2012; 12(18):1987-2001. PubMed ID: 23110534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of activity cliffs in structure-activity landscape of androgen receptor binding chemicals.
    Vivek-Ananth RP; Sahoo AK; Baskaran SP; Ravichandran J; Samal A
    Sci Total Environ; 2023 May; 873():162263. PubMed ID: 36801331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of individual compounds forming activity cliffs using emerging chemical patterns.
    Namasivayam V; Iyer P; Bajorath J
    J Chem Inf Model; 2013 Dec; 53(12):3131-9. PubMed ID: 24304008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposing the Limitations of Molecular Machine Learning with Activity Cliffs.
    van Tilborg D; Alenicheva A; Grisoni F
    J Chem Inf Model; 2022 Dec; 62(23):5938-5951. PubMed ID: 36456532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling Structure Activity Landscapes with Cliffs: a Kernel Regression-Based Approach.
    Tebby C; Mombelli E
    Mol Inform; 2013 Jul; 32(7):609-23. PubMed ID: 27481769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the validity versus utility of activity landscapes: are all activity cliffs statistically significant?
    Guha R; Medina-Franco JL
    J Cheminform; 2014; 6():11. PubMed ID: 24694189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do medicinal chemists learn from activity cliffs? A systematic evaluation of cliff progression in evolving compound data sets.
    Dimova D; Heikamp K; Stumpfe D; Bajorath J
    J Med Chem; 2013 Apr; 56(8):3339-45. PubMed ID: 23527828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity cliffs and activity cliff generators based on chemotype-related activity landscapes.
    Pérez-Villanueva J; Méndez-Lucio O; Soria-Arteche O; Medina-Franco JL
    Mol Divers; 2015 Nov; 19(4):1021-35. PubMed ID: 26150300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From activity cliffs to target-specific scoring models and pharmacophore hypotheses.
    Seebeck B; Wagener M; Rarey M
    ChemMedChem; 2011 Sep; 6(9):1630-9, 1533. PubMed ID: 21751401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity cliffs in PubChem confirmatory bioassays taking inactive compounds into account.
    Hu Y; Maggiora GM; Bajorath J
    J Comput Aided Mol Des; 2013 Feb; 27(2):115-24. PubMed ID: 23296990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs.
    Hu X; Hu Y; Vogt M; Stumpfe D; Bajorath J
    J Chem Inf Model; 2012 May; 52(5):1138-45. PubMed ID: 22489665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of target cliffs as a concept to identify and describe complex molecular selectivity patterns.
    Hu Y; Bajorath J
    J Chem Inf Model; 2013 Mar; 53(3):545-52. PubMed ID: 23379346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Error, Kurtosis, Activity Cliffs, and Methodology: What Limits the Predictivity of Quantitative Structure-Activity Relationship Models?
    Sheridan RP; Karnachi P; Tudor M; Xu Y; Liaw A; Shah F; Cheng AC; Joshi E; Glick M; Alvarez J
    J Chem Inf Model; 2020 Apr; 60(4):1969-1982. PubMed ID: 32207612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of activity landscapes using 2D and 3D similarity methods: consensus activity cliffs.
    Medina-Franco JL; Martínez-Mayorga K; Bender A; Marín RM; Giulianotti MA; Pinilla C; Houghten RA
    J Chem Inf Model; 2009 Feb; 49(2):477-91. PubMed ID: 19434846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.